🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In order to assess the potential impact of steady state BI 425809 on CYP3A ...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2022-03-18
Trial ID
NCT05258110
Treatments Being Tested
This study is open to adults with schizophrenia who took part in a previous...
Status
Terminated
Location
Advanced Research Center, Inc.
Start Date
2022-03-21
Trial ID
NCT05211947
Treatments Being Tested
The main objective of this trial is to investigate the relative bioavailabi...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2019-02-11
Trial ID
NCT03817476
Treatments Being Tested
The main objective of this trial is to investigate the possible effect of m...
Status
Completed
Location
CRS Clinical Research Services Mannheim GmbH
Start Date
2022-11-24
Trial ID
NCT05613777
Treatments Being Tested
The main objective of this trial is to investigate the potential effect of ...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2022-10-25
Trial ID
NCT05347004
Treatments Being Tested
The primary objective of this trial is to investigate the absolute oral bio...
Status
Completed
Location
ICON
Start Date
2019-01-15
Trial ID
NCT03783000
Treatments Being Tested
This trial intends to investigate the basic pharmacokinetics of BI 425809 a...
Status
Completed
Location
ICON
Start Date
2018-09-11
Trial ID
NCT03654170
Treatments Being Tested
The primary objective of this trial is to investigate the relative bioavail...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2017-03-28
Trial ID
NCT03082183
Treatments Being Tested
The main objective of this trial is to investigate the relative bioavailabi...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2023-03-06
Trial ID
NCT05723874
To investigate the safety, tolerability and pharmacokinetics of BI 425809 t...
Status
Completed
Location
1346.4.82001 Boehringer Ingelheim Investigational Site
Start Date
2015-05-11
Trial ID
NCT02383888